Cardioverter-defibrillator implantation and generator replacement in the octogenarian

Europace

Volumn 17, Issue 3, 2015, Pages 409-416

  Goonewardene, Manoj ^a   Barra, Sérgio ^a   Heck, Patrick ^a   Begley, David ^a   Fynn, Simon ^a   Virdee, Munmohan ^a   Grace, Andrew ^a   Agarwal, Sharad ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Elderly people; Generator replacement; Implantable cardioverter defibrillator; Mortality; Ventricular arrhythmias

Indexed keywords

AGED; AGING; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MORTALITY; COMORBIDITY; FEMALE; FOLLOW UP; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PACEMAKER IMPLANTATION; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SUDDEN CARDIAC DEATH; SURVIVAL; SURVIVAL TIME; VERY ELDERLY; COHORT ANALYSIS; DEATH, SUDDEN, CARDIAC; DEVICE REMOVAL; FACTUAL DATABASE; PROSPECTIVE STUDY; PROSTHESIS IMPLANTATION; REOPERATION; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

AGED, 80 AND OVER; COHORT STUDIES; DATABASES, FACTUAL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 84924419689     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu248     Document Type: Article

References (20)

1. Markowitz SM. Defibrillator implantation in the elderly: patients are older, but are physicians wiser? J Cardiovasc Electrophysiol 2010;21:242-4.
2. Krahn AD, Connolly SJ, Roberts RS, Gent M; ATMA Investigators. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J 2004;147:837-40.
3. Moss AJ, ZarebaW, Hall WJ, Klein H, Wilber DJ, CannomDSet al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-37.
5. Hohnloser SH, Kuck KH, DorianP, Roberts RS,Hampton JR, HatalaRet al.DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Eng J Med 2004;351:2481-8.
6. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmia after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigations. N Engl J Med 1966;335: 1933-40.
7. Kong MH, Al-Khatib SM, Sanders GD, Hasselblad V, Peterson ED. Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systemic literature review and meta-analysis. Cardiol J 2011;18:503-14.
8. Koplan BA, Epstein LM, Albert CM, StevensonWG.Survival in octogenarians receiving implantable defibrillators. Am Heart J 2006;152:714-9.
9. Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS et al. Role of the implantable defibrillatoramong elderly patients with a history of life threatening ventricular arrhythmias. Eur Heart J 2007;28:1746-9.
10. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators.Acomparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated fromnear-fatal ventricular arrhythmias.NEngl JMed 1997;337:1576-83.
11. Yung D, Birnie D, Dorian P, Healey JS, Simpson CS, Crystal E et al. Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation 2013; 127:2383-92.
12. Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE et al. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: Results from the NCDRw. Heart Rhythm 2014; 11:216-21.
13. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM et al. American College of Cardiology; American Geriatrics Society; American Academyof Hospice and Palliative Medicine;American Heart Association; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS Expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010;7:1008-26.
14. Lewis EF, Johnson PA, JohnsonW, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001;20:1016-24.
15. NoyesK,Corona E, Veazie P, DickAW,Zhao H, Moss AJ. Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II. Am J Cardiovasc Drugs 2009;9:393-400.
16. Schliamser JE, Kadish AH, Subacius H, Shalaby A, Schaechter A, Levine J et al. DEFINITE Investigators. Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE). Heart Rhythm 2013;10:838-46. .
17. KinchWesterdahl A, Sjoblom J, Mattiasson AC, Rosenqvist M, Frykman V. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life. Circulation 2014;129:422-9.
18. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SWet al. PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52:541-50.
19. Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB et al. Effect of long-detection interval vs. standard-detection interval for implantable cardioverterdefibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA 2013;309:1903-11.
20. Moss AJ, Schuger C, Beck CA, BrownMW,CannomDS, Daubert JP et al. MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012;367:2275-83.